PTEN and prostate carcinoma: Finally, phosphatase and tensin homolog (PTEN) deletions have also been identified in up to 20% of primary prostate cancer and have been associated with higher Gleason grade, tumor progression, and early prostate serum antigen (PSA) recurrence (20–22).